Literature DB >> 30831465

Protective effect of 7,3',4'-flavon-3-ol (fisetin) on acetaminophen-induced hepatotoxicity in vitro and in vivo.

Licong Zhao1, Jiaqi Zhang2, Lingyun Pan2, Long Chen2, Yu Wang2, Xinhua Liu2, Lisha You3, Yiqun Jia4, Cheng Hu5.   

Abstract

BACKGROUND: Acetaminophen (APAP) overdose is a leading cause of drug-induced acute liver failure in clinic. Fisetin (FST) is a phenolic compound that has been isolated from many natural products.
PURPOSE: Our aim is to study the protection effect and mechanisms of FST on APAP-induced hepatotoxicity in endogenous metabolism and metabolomics in vitro and in vivo.
METHODS: FST was i.g. administered to mice at 10, 20 and 40 mg/kg for 7 days and a single dose of APAP (400 mg/kg) was given on the last day. Serum and tissue were collected for biochemical analysis. L-02 cells were used to assess cell viability. LC-MS was used to study the metabolic fingerprinting in vivo and vitro. PCA and OPLS-DA were used to search the potential biomarkers (VIP > 1, p < 0.05). The pathway analysis was conducted on Metaboanalyst 4.0. Then liver oxidative stress indices and glutathione markers were examined using PCR and kits.
RESULTS: ALT, AST, liver histological observation and cell viability results showed that FST could reverse APAP induced toxicology in mice and L-02 cells. In metabolomics study, 26 metabolites in vitro and 60 metabolites in vivo were identified by searching in the library and most of them decreased to normal level in FST treatment. It is observed in pathway analysis that the most significant pathway was glutathione metabolism. Furthermore, the results of mRNA and immunofluorescence showed that FST suppressed ROS formation in liver tissue and L-02 cells, as well as restored the expression of GPX1, GST and other antioxidative enzymes genes.
CONCLUSION: Our results indicate that FST prevented APAP-induced hepatotoxicity by regulating glutathione metabolism and the expression of related antioxidative signals.
Copyright © 2019 Elsevier GmbH. All rights reserved.

Entities:  

Keywords:  Acetaminophen; Fisetin; Glutathione; Hepatotoxicity; Metabolomics

Mesh:

Substances:

Year:  2019        PMID: 30831465     DOI: 10.1016/j.phymed.2019.152865

Source DB:  PubMed          Journal:  Phytomedicine        ISSN: 0944-7113            Impact factor:   5.340


  5 in total

1.  Fisetin Attenuated Oxidative Stress-Induced Cellular Damage in ARPE-19 Human Retinal Pigment Epithelial Cells Through Nrf2-Mediated Activation of Heme Oxygenase-1.

Authors:  Cheol Park; Jeong Sook Noh; Youngmi Jung; Sun-Hee Leem; Jin Won Hyun; Young-Chae Chang; Taeg Kyu Kwon; Gi-Young Kim; Hyesook Lee; Yung Hyun Choi
Journal:  Front Pharmacol       Date:  2022-06-16       Impact factor: 5.988

2.  Apigenin Prevents Acetaminophen-Induced Liver Injury by Activating the SIRT1 Pathway.

Authors:  Licong Zhao; Jiaqi Zhang; Cheng Hu; Tao Wang; Juan Lu; Chenqu Wu; Long Chen; Mingming Jin; Guang Ji; Qin Cao; Yuanye Jiang
Journal:  Front Pharmacol       Date:  2020-04-24       Impact factor: 5.810

3.  The Protective Effects of Imperatorin on Acetaminophen Overdose-Induced Acute Liver Injury.

Authors:  Zhao Gao; Jiecheng Zhang; Li Wei; Xingping Yang; Yuan Zhang; Bo Cheng; Zehong Yang; Weihang Gao; Chunhui Song; Wei Miao; Kevin Williams; Changhui Liu; Qin Xu; Yongsheng Chang; Yong Gao
Journal:  Oxid Med Cell Longev       Date:  2020-05-13       Impact factor: 6.543

4.  Fisetin Attenuates Diabetic Nephropathy-Induced Podocyte Injury by Inhibiting NLRP3 Inflammasome.

Authors:  Wenmin Dong; Chenglin Jia; Ji Li; Yi Zhou; Yun Luo; Jibo Liu; Zhiguo Zhao; Jiaqi Zhang; Shan Lin; Ying Chen
Journal:  Front Pharmacol       Date:  2022-01-21       Impact factor: 5.810

Review 5.  Hepatic, Extrahepatic and Extracellular Vesicle Cytochrome P450 2E1 in Alcohol and Acetaminophen-Mediated Adverse Interactions and Potential Treatment Options.

Authors:  Santosh Kumar; Bhupesh Singla; Ajay K Singh; Stacey M Thomas-Gooch; Kaining Zhi; Udai P Singh
Journal:  Cells       Date:  2022-08-23       Impact factor: 7.666

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.